Ozempic Archives - PMC Herbals

Ozempic 0.25mg Injection

Joyce Bhatia — Fri, 31 Jul 2026 12:00:37 +0000

Ozempic 0.25 mg Injection – Semaglutide for Type 2 Diabetes Management

Ozempic 0.25 mg Injection is a prescription injectable medicine containing Semaglutide 0.25 mg per dose. It is used alongside diet and regular physical activity to improve blood-sugar control in adults with type 2 diabetes mellitus. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps increase insulin release when blood sugar is elevated, reduces excess glucagon secretion, and slows gastric emptying. Ozempic 0.25 mg is generally used as the starting dose for the first four weeks to help the body adjust to treatment. It is not normally used as a long-term maintenance dose.

Key Features

Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
0.25 mg Per Dose: Each prescribed injection delivers 0.25 mg of semaglutide.
Starting-Dose Strength: Generally used during the first four weeks of treatment.
Supports Blood-Sugar Control: Helps reduce elevated glucose levels in adults with type 2 diabetes.
Once-Weekly Administration: Designed for use on the same day each week.
Pre-Filled Pen: Allows convenient subcutaneous administration.
Four-Dose Presentation: The 0.25 mg pen provides four weekly doses and is supplied with four disposable needles.

Active Ingredient

Semaglutide 0.25 mg per dose: A GLP-1 receptor agonist that supports glucose-dependent insulin release, reduces excess glucagon secretion, and slows stomach emptying.

Uses

Improvement of blood-sugar control in adults with type 2 diabetes mellitus.
Used alongside an appropriate diet and regular physical activity.
May be prescribed alone when metformin is unsuitable.
May be prescribed with other diabetes medicines when additional glucose control is required.
Initial dose-escalation stage before moving to a higher prescribed semaglutide dose.

How to Use

Do not inject it into a vein or muscle.
Rotate the injection site with every weekly dose.
Attach a new compatible disposable needle before every injection.
Check the medicine flow before the first injection from each new pen.
Turn the dose selector until the dose counter displays 0.25 mg.
Press and hold the dose button until the dose counter returns to zero.
Remove and safely discard the needle immediately after every injection.
Never share the injection pen or needles with another person.

Missed Dose

If five days or fewer have passed since the missed dose, inject it as soon as remembered.
Take the next dose on the regularly scheduled weekly day.
If more than five days have passed, skip the missed dose.
Do not inject a double dose to compensate for a missed dose.

Precautions

Ozempic 0.25 mg is a starting dose and should not be increased without medical advice.
It is not intended for type 1 diabetes or diabetic ketoacidosis.
Nausea, vomiting, and diarrhoea may cause dehydration and may affect kidney function.
The risk of low blood sugar may increase when used with insulin or sulfonylurea medicines.
Report sudden or worsening changes in vision promptly.
Inform healthcare professionals that you use semaglutide before surgery, general anaesthesia, or deep sedation.
Do not combine it with another semaglutide product or GLP-1 receptor agonist unless specifically prescribed.

Possible Side Effects

Nausea.
Vomiting.
Diarrhoea.
Constipation.
Indigestion or acid reflux.
Reduced appetite.
Headache or dizziness.
Fatigue.

Storage

Before first use, store the pen in a refrigerator between 2°C and 8°C.
Do not freeze or use a pen that has been frozen.
Keep the pen cap attached to protect the medicine from light.
During use, store below 30°C or in a refrigerator between 2°C and 8°C for up to six weeks.
Do not store the pen with a needle attached.
Keep out of the sight and reach of children.

Legal Disclaimer: Ozempic 0.25 mg Injection is a prescription semaglutide medicine intended for adults with type 2 diabetes. The 0.25 mg strength is generally an initial dose and is not intended as a long-term maintenance dose. Dose escalation, treatment duration, and combination with other diabetes medicines must be determined by a qualified healthcare professional. This information is provided for educational purposes and should not replace the official product instructions.

The post Ozempic 0.25mg Injection appeared first on PMC Herbals.

Ozempic 0.5mg Injection

Joyce Bhatia — Mon, 12 Jan 2026 10:43:32 +0000

Ozempic 0.5 mg Injection – Semaglutide for Type 2 Diabetes Management

Ozempic 0.5 mg Injection is a prescription injectable medicine containing Semaglutide 0.5 mg per dose. It is used alongside an appropriate diet and regular physical activity to improve blood-sugar control in adults with type 2 diabetes mellitus. Semaglutide belongs to a group of medicines called glucagon-like peptide-1 receptor agonists, also known as GLP-1 receptor agonists. It helps the body release insulin when blood sugar is elevated, reduces excess glucagon secretion, and slows gastric emptying. The 0.5 mg strength is generally used after the initial four-week treatment period with Ozempic 0.25 mg. The exact pen volume, total semaglutide content, number of doses, and included needles may vary according to the marketed pack.

Key Features

Contains Semaglutide: A long-acting GLP-1 receptor agonist.
0.5 mg Per Dose: Each prescribed injection delivers 0.5 mg of semaglutide.
Once-Weekly Administration: Used on the same day every week.
Supports Blood-Sugar Control: Helps reduce elevated glucose levels in adults with type 2 diabetes.
Pre-filled Pen: Designed for convenient subcutaneous administration.
Prescription Medicine: Should be used according to a healthcare professional’s treatment plan.

Active Ingredient

Semaglutide 0.5 mg per dose

Uses

Management of type 2 diabetes mellitus in adults.
Improvement of blood-glucose control alongside diet and physical activity.
May be used alone when metformin is unsuitable.
May be used with other diabetes medicines when additional glucose control is required.
Supports reduction of HbA1c as part of a medically supervised diabetes-management programme.

How to Use

Use Ozempic 0.5 mg exactly as prescribed by your healthcare professional.
Inject one 0.5 mg dose once weekly on the same day each week.
It may be administered at any time of the day, with or without meals.
Inject it under the skin of the abdomen, thigh, or upper arm.
Do not inject it into a vein or muscle.
Rotate the injection site with every weekly administration.
Attach a new compatible disposable needle before every injection.
Check that the solution is clear and colourless or almost colourless before use.
Check the medicine flow before the first injection from each new pen.
Turn the dose selector until the dose counter displays exactly 0.5 mg.
Do not select the dose by counting pen clicks.

Missed Dose

If five days or fewer have passed since the missed dose, administer it as soon as remembered.
Take the following dose on the regularly scheduled weekly day.
If more than five days have passed, skip the missed dose.
Do not administer a double dose to compensate for a missed dose.

Precautions

Ozempic 0.5 mg is generally used after the initial 0.25 mg dose-escalation period.
It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.
Inform your doctor if you have pancreatitis, kidney problems, gallbladder disease, severe digestive problems, delayed stomach emptying, or diabetic retinopathy.
Nausea, vomiting, and diarrhoea may cause dehydration.
The risk of low blood sugar may increase when used with insulin or sulfonylurea medicines.
Seek medical attention for severe and persistent abdominal pain.
Report sudden or worsening changes in vision promptly.
Do not use it with another semaglutide product or GLP-1 receptor agonist unless prescribed.

Possible Side Effects

Nausea.
Vomiting.
Diarrhoea.
Constipation.
Abdominal pain or discomfort.
Indigestion or acid reflux.
Bloating, burping, or increased gas.
Reduced appetite.
Headache or dizziness.
Fatigue.
Injection-site redness, itching, or irritation.
Low blood sugar when combined with certain diabetes medicines.
Gallstones or gallbladder inflammation.

Storage

Before first use, store the pen in a refrigerator between 2°C and 8°C.
Keep the pen away from the refrigerator’s cooling element.
Do not freeze or use a pen that has been frozen.
Keep the pen cap attached to protect the medicine from light.
During use, store below 30°C or refrigerated between 2°C and 8°C for up to six weeks.
Do not store the pen with a needle attached.
Do not use the solution if it appears cloudy, coloured, or contains visible particles.
Keep out of the sight and reach of children.

Legal Disclaimer: Ozempic 0.5 mg Injection is a prescription semaglutide medicine intended for adults with type 2 diabetes mellitus. The dose, treatment duration, and combination with other diabetes medicines must be determined by a qualified healthcare professional. This information is provided for general product-information purposes and should not replace the official instructions supplied with the medicine.

The post Ozempic 0.5mg Injection appeared first on PMC Herbals.

Ozempic 1mg Injection

Joyce Bhatia — Mon, 12 Jan 2026 10:34:04 +0000

Ozempic 1 mg Injection – Semaglutide for Type 2 Diabetes Management

Ozempic 1 mg Injection is a prescription injectable medicine containing Semaglutide 1 mg per dose. It is used alongside an appropriate diet and regular physical activity to improve blood-sugar control in adults with type 2 diabetes mellitus. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps increase insulin release when blood glucose is elevated, reduces excess glucagon secretion, and slows gastric emptying. The 1 mg strength is generally used after treatment with lower Ozempic doses. Depending on the marketed presentation, a 3 mL pre-filled pen may contain four or eight fixed doses of 1 mg. Confirm the exact number of doses and needles from the supplied pack.

Key Features

Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
1 mg Per Dose: Each prescribed injection delivers 1 mg of semaglutide.
Supports Blood-Sugar Control: Helps reduce elevated glucose levels in adults with type 2 diabetes.
Once-Weekly Administration: Designed for use on the same day each week.
Pre-Filled Pen: Allows convenient subcutaneous administration.
Prescription Medicine: Must be used according to a healthcare professional’s treatment plan.

Active Ingredient

Semaglutide 1 mg per dose: A GLP-1 receptor agonist that supports glucose-dependent insulin release, reduces excess glucagon secretion, and slows stomach emptying.

Uses

Management of insufficiently controlled type 2 diabetes mellitus in adults.
Improvement of blood-glucose control alongside diet and regular physical activity.
May be used alone when metformin is unsuitable.
May be prescribed with other diabetes medicines when additional glucose control is required.
Supports reduction of HbA1c as part of a medically supervised diabetes-management programme.

How to Use

Inject one prescribed dose once weekly on the same day each week.
Inject it under the skin of the abdomen, thigh, or upper arm.
Do not inject it into a vein or muscle.
Rotate the injection site with every weekly dose.
Attach a new compatible disposable needle before each injection.
Check the medicine flow before the first injection from each new pen.
Turn the dose selector until the dose counter displays exactly 1 mg.
Press and hold the dose button until the dose counter returns to zero.
Keep the needle under the skin and count slowly to six before removing it.
Remove and safely discard the needle immediately after each injection.

Missed Dose

If five days or fewer have passed since the missed dose, inject it as soon as remembered.
Take the following dose on the regularly scheduled weekly day.
If more than five days have passed, skip the missed dose.
Do not inject a double dose to compensate for a missed dose.

Precautions

Ozempic 1 mg is generally used after gradual dose escalation from lower strengths.
It is not intended for type 1 diabetes or diabetic ketoacidosis.
Nausea, vomiting, and diarrhoea may cause dehydration and affect kidney function.
Seek prompt medical advice for sudden or worsening changes in vision.
Inform healthcare professionals that you use semaglutide before surgery, general anaesthesia, or deep sedation.
Do not combine it with another semaglutide product or GLP-1 receptor agonist unless specifically prescribed.

Possible Side Effects

Nausea.
Vomiting.
Diarrhoea.
Constipation.
Abdominal pain or discomfort.
Indigestion or acid reflux.
Bloating, burping, or increased gas.
Reduced appetite.
Headache or dizziness.
Fatigue.
Gallstones or gallbladder inflammation.

Storage

Before first use, store the pen in a refrigerator between 2°C and 8°C.
Keep the pen away from the refrigerator’s cooling element.
Do not freeze or use a pen that has been frozen.
Keep the pen cap attached to protect the medicine from light.
After first use, store below 30°C or refrigerated between 2°C and 8°C.
A four-dose pen may be stored for up to six weeks after first use.
An eight-dose pen may be stored for up to eight weeks after first use.
Do not store the pen with a needle attached.
Do not use if the solution is cloudy, coloured, or contains visible particles.
Keep out of the sight and reach of children.

Legal Disclaimer: Ozempic 1 mg Injection is a prescription semaglutide medicine intended for adults with type 2 diabetes mellitus. The 1 mg strength is generally used after gradual dose escalation. Dose selection, treatment duration, and combination with other diabetes medicines must be determined by a qualified healthcare professional. This information is provided for educational purposes and should not replace the official product instructions.

The post Ozempic 1mg Injection appeared first on PMC Herbals.